DubaiUAE, January 27, 2025 / Prnewswire / – the day before Arab health exhibitionYuwell Medical held its 2025 Global Core Partner Conference In Dubaiand announced a Strategic investment and partnership with Inogena leading U.S. respiratory health company, highlighting our joint commitment to advancing medical device solutions and deeper collaboration.
Speaking at Yuwell Medical’s Global Core Partner Conference 2025, Alex Wu, President of Yuwell Medical, said that as a leading company in China The home medical device industry, Yuwell will rely on internal growth and external mergers and acquisitions to promote internationalization. The company updated its new vision for the next five years: to become the top three companies in the global medical home health market in the mid-to-late term. Among them, respiratory treatment solutions, diabetes care and emergency services solutions are the three key strategic sectors. The company will further strengthen its globalization strategy from three aspects: expansion of organizational structure, recruitment of outstanding talents from abroad, product R&D innovation and innovation of supply chain integration. supply.
He further emphasized: “In the process of realizing the new vision, Yuwell will work hand in hand with global partners to provide users with more competitive products and better health solutions.”
During the conference, Yuwell Medical and the American company Inogen formalized their collaboration by signing a Strategic Investment and Cooperation Memorandumfurther deepening their partnership in the respiratory segment.
As one of the world’s largest oxygen concentrator manufacturers, Yuwell Medical is widely recognized for its strong R&D capabilities and advanced manufacturing capabilities.
Inogen, a leading US oxygen concentrator manufacturer, brings extensive experience in portable oxygen concentrator technology. Yuwell, through all its subsidiary owned by Yuwell (Hong Kong) Holdings Limited, has agreed to invest approximately $27.2 million In Inogen, representing 9.9% of Inogen’s common stock as of the closing of this investment.
Both companies seek to improve device technology through extensive collaboration. By combining their expertise and brand in their respective industry segments and geographies, Yuwell and Inogen agree to carry out in-depth strategic cooperation based on business synergy in four aspects: International distribution business, licensing and distribution business branding, joint research and development, and supply chain optimization.
Yuwell Medical and Inogen are excited to build a long-term strategic partnership, ready to take advantage of emerging opportunities in today’s market. Together, they aim to improve their international competitiveness and provide innovative products that improve lives around the world.
In the meantime, Yuwell Medical will remain focused on innovationdriving breakthroughs in medical technology and working with global partners to shape the future of healthcare.
Source Yuwell Medical
